Markers of injury and fibrosis in occupational interstitial lung diseases (OILD)

Galina P. Orlova (Saint Petersburg, Russian Federation), Galina Orlova, Elena Surkova

Source: International Congress 2015 – Occupational disease: clinical cases and series
Session: Occupational disease: clinical cases and series
Session type: Thematic Poster Session
Number: 1160
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Galina P. Orlova (Saint Petersburg, Russian Federation), Galina Orlova, Elena Surkova. Markers of injury and fibrosis in occupational interstitial lung diseases (OILD). Eur Respir J 2015; 46: Suppl. 59, 1160

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Biomarkers for interstitial lung disease
Source: International Congress 2016 – ME1 Biomarkers for interstitial lung disease
Year: 2016



Smoking and interstitial lung diseases
Source: Annual Congress 2013 –Tobacco use in different countries: crisis to disease
Year: 2013

"Cyclophosphamide for the treatment of inflammation driven fibrotic interstitial lung disease"
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014

The prognostic factor in patients with myositis-associated interstitial lung disease
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014


Asbestos-related disorders (ARDs): Influence of pleural plaques and pulmonary fibrosis due to asbestos exposure on lung function decline (LFD)
Source: International Congress 2014 – ILDs 5
Year: 2014


Statin-induced lung diseases
Source: International Congress 2016 – Sarcoidosis
Year: 2016


Characterization of emphysema in active farmer’s lung disease
Source: International Congress 2016 – Occupational epidemiology
Year: 2016

HCMV infection triggers the development of interstitial lung diseases in autoimmune disorders
Source: International Congress 2014 – IPF and surroundings
Year: 2014


Rare interstitial lung diseases of environmental origin
Source: Eur Respir Mon 2011; 54: 301-316
Year: 2011


The role of detection of myositis specific and associated antibodies in Japanese patient with interstitial lung disease
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014


Study of factors affecting mortality in ILD cases over 2 years
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016


Novel lung function tests in patients with interstitial lung disease (ILD)
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016

Variation in mortality from interstitial lung disease by diagnosis
Source: International Congress 2015 – IIPs: orphan
Year: 2015


Does CRP predicts severity of hospitalized patients with diffuse interstitial lung disease?
Source: International Congress 2014 – ILDs 5
Year: 2014

Addition of respiratory hospitalizations 24weeks prior to the ILD-GAP model to predict mortality in chronic interstitial lung disease
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016


Distribution of pleural plaques and pulmonary fibrosis due to asbestos exposure: Radiological patterns in asbestos-related disorders (ARDs)
Source: International Congress 2015 – Interstitial lung diseases I
Year: 2015


Occupational interstitial lung disease
Source: Eur Respir Mon; 2009: 46: 265–286
Year: 2009

Aetiological panorama in the diagnosis of interstitial lung diseases
Source: International Congress 2014 – ILDs 5
Year: 2014


Smoking and interstitial lung diseases
Source: Eur Respir Rev 2015; 24: 428-435
Year: 2015



Relevance of the expert ILD clinical-radiological evaluation of referred cases to the MDT
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016